You have 9 free searches left this month | for more free features.

MC1R genotype

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Stroke Trial in Laval (Cardiovascular training, Standard Therapy)

Recruiting
  • Stroke
  • Cardiovascular training
  • Standard Therapy
  • Laval, Quebec, Canada
    Jewish Rehabiliation Hospital
Nov 17, 2022

Skin Cancer Trial in Salt Lake City (Education, Action Plan, UV Photo)

Not yet recruiting
  • Skin Cancer
  • Education
  • +3 more
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Dec 1, 2022

Healthy Lifestyle, Taste Disorders, Diet Habit Trial in Poznan (Intervention genotype personalized nutritional recommendations,

Completed
  • Healthy Lifestyle
  • +2 more
  • Intervention genotype personalized nutritional recommendations
  • +2 more
  • Poznań, Poland
    Poznan University of Life Sciences
Jul 7, 2022

Children and Adults With CTNNB1 Mutation

Completed
  • CTNNB1 Gene Mutation
  • The Modified Checklist for Autism in Toddlers, Revised with Follow-Up (M-CHAT-R/F)
  • +15 more
  • Sydney, Australia
  • +2 more
Nov 1, 2022

Leukemia, Relapsed, Myeloid Trial in Netherlands, Switzerland (MP0533 (multispecific DARPin CD3 Engager Targeting CD33, CD123

Recruiting
  • Leukemia
  • +3 more
  • MP0533 (multispecific DARPin CD3 Engager Targeting CD33, CD123 and CD70)
  • Amsterdam, Netherlands
  • +4 more
Jan 4, 2023

Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for Ribavirin)

Completed
  • Chronic Hepatitis C Infection
  • ABT-450/r/ABT-267, ABT-333
  • +2 more
  • (no location specified)
Jul 8, 2021

Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ribavirin)

Completed
  • Chronic Hepatitis C Infection
  • ABT-450/r/ABT-267, ABT-333
  • +2 more
  • (no location specified)
Jul 8, 2021

Chronic Hepatitis C Infection, Compensated Cirrhosis Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))

Completed
  • Chronic Hepatitis C Infection
  • Compensated Cirrhosis
  • ABT-450/r/ABT-267, ABT-333
  • Ribavirin (RBV)
  • (no location specified)
Jul 8, 2021

Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ABT-450/r/ABT-267)

Completed
  • Chronic Hepatitis C Infection
  • ABT-450/r/ABT-267, ABT-333
  • +4 more
  • (no location specified)
Jul 29, 2021

Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ABT-450/r/ABT-267)

Completed
  • Chronic Hepatitis C Infection
  • ABT-450/r/ABT-267, ABT-333
  • +4 more
  • (no location specified)
Jul 8, 2021

Chronic Hepatitis C Virus (HCV) Infection Genotype 1 Trial in United States (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))

Completed
  • Chronic Hepatitis C Virus (HCV) Infection Genotype 1
  • Phoenix, Arizona
  • +47 more
Jun 27, 2022

Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin)

Completed
  • Chronic Hepatitis C Infection
  • (no location specified)
Jul 8, 2021

Melanoma, Young Adult Trial in Salt Lake City (diagnostic test, other, device)

Completed
  • Melanoma
  • Young Adult
  • MC1R Genetic Testing
  • +2 more
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Jul 9, 2021

Hepatitis C, Chronic Trial in United States (ombitasvir, paritaprevir/r, dasabuvir + ribavirin, ombitasvir, paritaprevir/r,

Completed
  • Hepatitis C, Chronic
  • ombitasvir, paritaprevir/r, dasabuvir + ribavirin
  • ombitasvir, paritaprevir/r, dasabuvir
  • Irvine, California
  • +3 more
Jan 21, 2021

Chronic Hepatitis C Trial (Danoprevir, Ritonavir, peginterferon alfa-2a)

Completed
  • Chronic Hepatitis C
  • (no location specified)
Feb 28, 2021

Vitamin D Deficiency, Vitamin D Insufficiency Trial in Worldwide (Calcifediol 75mcg, Calcifediol 100mcg, Calcifediol 125mcg)

Active, not recruiting
  • Vitamin D Deficiency
  • Vitamin D Insufficiency
  • Calcifediol 75mcg
  • +3 more
  • Sevlievo, Bulgaria
  • +54 more
May 2, 2022

Phenotype/Genotype Correlations in Movement Disorders

Recruiting
  • Movement Disorder
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    ALS, FTD Trial in Worldwide (WVE-004, Placebo)

    Active, not recruiting
    • ALS
    • FTD
    • North Ryde, New South Wales, Australia
    • +16 more
    Feb 2, 2023

    Recurrent Severe Aplastic Anemia, Refractory Severe Aplastic Anemia Trial in Duarte (biological, procedure, drug, other)

    Not yet recruiting
    • Recurrent Severe Aplastic Anemia
    • Refractory Severe Aplastic Anemia
    • Anti-Thymocyte Globulin
    • +7 more
    • Duarte, California
      City of Hope Medical Center
    Feb 23, 2023

    Early Alzheimer's Disease Trial in Worldwide (Experimental: ALZ-801, Placebo Comparator: Placebo)

    Recruiting
    • Early Alzheimer's Disease
    • Experimental: ALZ-801
    • Placebo Comparator: Placebo
    • Phoenix, Arizona
    • +95 more
    Aug 18, 2022

    Hereditary Hemorrhagic Telangiectasia, HHT, Rendu Osler Weber Disease Trial in Madrid (Registry)

    Recruiting
    • Hereditary Hemorrhagic Telangiectasia
    • +2 more
    • Registry
    • Madrid, Spain
      Hospital Universitario Ramón y Cajal
    Sep 30, 2022